glp-1 for ckd Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists GLP-1 RAs, Other Agents, Underused

From Pubchem IUPAC Name: (4S)-4-[[(2S)-2-aminopropanoyl] amino]-5-[[(2S)-3-carboxy-1-(carboxymethylamino)-1-oxopropan-2-yl] amino]-5-oxopentanoic acid Synonyms: Epithalone, alanyl-glutamyl-aspartyl-glycine, epitalon, epithalon Molecular Formula: C14H22N4O9 Molecular Weight: 390.35 g/mol Sequence: Ala-Glu-Asp-Gly CAS number: 307297-39-8 PubChem CID: 219042 Epithalon was initially researched and developed in Russia by Dr

GLP-1, Microbiome & SCFAs: A Blueprint for Metabolic Health What youll learn: Why GLP-1 medications cannot rebuild the metabolic system and how microbiome repair, SCFAs, and circadian biology create long-term metabolic stability

Sleep quality sometimes improves as body composition improves

Wang, P

Complementing GLP-1 medications like semaglutide or tirzepatide

Their main mechanism of action consists in the inhibition of SGLT receptors, of which two different isoforms are known, SGLT1 and SGLT2